{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:36Z","timestamp":1790794176723,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25293141"],"award-info":[{"award-number":["25293141"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26670313"],"award-info":[{"award-number":["26670313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26293198"],"award-info":[{"award-number":["26293198"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04182"],"award-info":[{"award-number":["17H04182"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04126"],"award-info":[{"award-number":["17H04126"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04123"],"award-info":[{"award-number":["17H04123"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K18450"],"award-info":[{"award-number":["18K18450"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["dk0207006"],"award-info":[{"award-number":["dk0207006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["dk0207027"],"award-info":[{"award-number":["dk0207027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0109070"],"award-info":[{"award-number":["ek0109070"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0109283"],"award-info":[{"award-number":["ek0109283"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0109196"],"award-info":[{"award-number":["ek0109196"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0109348"],"award-info":[{"award-number":["ek0109348"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["kk0205008"],"award-info":[{"award-number":["kk0205008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0210066"],"award-info":[{"award-number":["ek0210066"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0210096"],"award-info":[{"award-number":["ek0210096"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["ek0210116"],"award-info":[{"award-number":["ek0210116"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["le0110005"],"award-info":[{"award-number":["le0110005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-intractable diseases-general-027"],"award-info":[{"award-number":["H29-intractable diseases-general-027"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-intractable diseases-general-027"],"award-info":[{"award-number":["H29-intractable diseases-general-027"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008608","name":"Sumitomo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation for Healthy Ageing"},{"name":"Research on Region Medical","award":["H28-iryo-ippan-016, H30-iryo-ippan-009"],"award-info":[{"award-number":["H28-iryo-ippan-016, H30-iryo-ippan-009"]}]},{"name":"Research on Region Medical","award":["H28-iryo-ippan-016, H30-iryo-ippan-009"],"award-info":[{"award-number":["H28-iryo-ippan-016, H30-iryo-ippan-009"]}]},{"name":"Health, Labour and Welfare Sciences Research Grants"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Subjects with subclinical respiratory dysfunction who do not meet the chronic obstructive pulmonary disease (COPD) criteria have attracted attention with regard to early COPD intervention. Our aim was to longitudinally investigate the risks for the development of airflow limitation (AFL) and dyspnoea, the main characteristics of COPD, in a large-scale community-based general population study. The Nagahama study included 9789 inhabitants, and a follow-up evaluation was conducted after 5\u00a0years. AFL was diagnosed using a fixed ratio (forced expiratory volume in one second (FEV<jats:sub>1<\/jats:sub>)\/forced vital capacity (FVC)\u2009&lt;\u20090.7). We enrolled normal subjects aged 40\u201375\u00a0years with no AFL, dyspnoea or prior diagnosis of asthma or COPD at baseline. In total, 5865 subjects were analysed, 310 subjects had subclinical respiratory dysfunction (FEV<jats:sub>1<\/jats:sub>\/FVC\u2009&lt;\u2009the lower limit of normal; n\u2009=\u200957, and FEV<jats:sub>1<\/jats:sub>\u2009&lt;\u200980% of the predicted value (preserved ratio impaired spirometry); n\u2009=\u2009256). A total of 5086 subjects attended the follow-up assessment, and 449 and 1021 subjects developed AFL and dyspnoea, respectively. Of these, 100 subjects developed AFL with dyspnoea. Baseline subclinical respiratory dysfunction was independently and significantly associated with AFL with dyspnoea development within 5\u00a0years. Subjects with subclinical respiratory dysfunction are at risk of developing COPD-like features and require careful monitoring.<\/jats:p>","DOI":"10.1038\/s41598-022-24657-w","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:11:54Z","timestamp":1669162314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study"],"prefix":"10.1038","volume":"12","author":[{"given":"Mariko","family":"Kogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sunadome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"24657_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1440-1843.2004.00637.x","volume":"9","author":"Y Fukuchi","year":"2004","unstructured":"Fukuchi, Y. et al. COPD in Japan: The Nippon COPD Epidemiology study. Respirology 9, 458\u2013465 (2004).","journal-title":"Respirology"},{"key":"24657_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1440-1843.2003.00501.x","volume":"8","author":"T Takahashi","year":"2003","unstructured":"Takahashi, T. et al. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 8, 504\u2013508 (2003).","journal-title":"Respirology"},{"key":"24657_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","volume":"374","author":"PG Woodruff","year":"2016","unstructured":"Woodruff, P. G. et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N. Engl. J. Med. 374, 1811\u20131821 (2016).","journal-title":"N. Engl. J. Med."},{"key":"24657_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2310\/JIM.0b013e31822bb213","volume":"59","author":"CA Vaz Fragoso","year":"2011","unstructured":"Vaz Fragoso, C. A. et al. Respiratory impairment and mortality in older persons: A novel spirometric approach. J. Investig. Med. 59, 1089\u20131095 (2011).","journal-title":"J. Investig. Med."},{"key":"24657_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1164\/rccm.201307-1240OC","volume":"189","author":"H Van Remoortel","year":"2014","unstructured":"Van Remoortel, H. et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 189, 30\u201338 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR6","doi-asserted-by":"publisher","first-page":"1902217","DOI":"10.1183\/13993003.02217-2019","volume":"55","author":"A Adibi","year":"2020","unstructured":"Adibi, A. & Sadatsafavi, M. Looking at the COPD spectrum through \u201cPRISm\u201d. Eur. Respir. J. 55, 1902217. https:\/\/doi.org\/10.1183\/13993003.02217-2019 (2020).","journal-title":"Eur. Respir. J."},{"key":"24657_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347\u2013365 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1164\/rccm.200508-1211ST","volume":"173","author":"L Nici","year":"2006","unstructured":"Nici, L. et al. American Thoracic Society\/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 173, 1390\u20131413 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli, B. R. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005\u20131012 (2004).","journal-title":"N. Engl. J. Med."},{"key":"24657_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","volume":"15","author":"ES Wan","year":"2014","unstructured":"Wan, E. S. et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir. Res. 15, 89. https:\/\/doi.org\/10.1186\/s12931-014-0089-y (2014).","journal-title":"Respir. Res."},{"key":"24657_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/thx.2009.126052","volume":"65","author":"S Guerra","year":"2010","unstructured":"Guerra, S. et al. Morbidity and mortality associated with the restrictive spirometric pattern: A longitudinal study. Thorax 65, 499\u2013504 (2010).","journal-title":"Thorax"},{"key":"24657_CR12","doi-asserted-by":"publisher","first-page":"1901217","DOI":"10.1183\/13993003.01217-2019","volume":"55","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant, S. R. A. et al. Trajectory and mortality of preserved ratio impaired spirometry: The Rotterdam Study. Eur. Respir. J. 55, 1901217. https:\/\/doi.org\/10.1183\/13993003.01217-2019 (2020).","journal-title":"Eur. Respir. J."},{"key":"24657_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12931-018-0896-7","volume":"19","author":"HJ Park","year":"2018","unstructured":"Park, H. J. et al. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: A 3-year cohort study. Respir. Res. 19, 185. https:\/\/doi.org\/10.1186\/s12931-018-0896-7 (2018).","journal-title":"Respir. Res."},{"key":"24657_CR14","doi-asserted-by":"crossref","unstructured":"Mohamed Hoesein, F. A., Zanen, P., Lammers, J. W. Lower limit of normal or FEV1\/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir. Med. 105, 907\u2013915 (2011)","DOI":"10.1016\/j.rmed.2011.01.008"},{"key":"24657_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1164\/rccm.200909-1366OC","volume":"181","author":"CA Vaz Fragoso","year":"2010","unstructured":"Vaz Fragoso, C. A. et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181, 446\u2013451 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S2213-2600(13)70137-1","volume":"1","author":"M Thomsen","year":"2013","unstructured":"Thomsen, M., Nordestgaard, B. G., Vestbo, J. & Lange, P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: A prospective population study. Lancet Respir. Med. 1, 543\u2013550 (2013).","journal-title":"Lancet Respir. Med."},{"key":"24657_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1513\/AnnalsATS.201703-194OC","volume":"15","author":"PMA Calverley","year":"2018","unstructured":"Calverley, P. M. A., Mueller, A., Fowler, A., Metzdorf, N. & Wise, R. A. The effect of defining chronic obstructive pulmonary disease by the lower limit of normal of FEV1\/FVC ratio in tiotropium safety and performance in respimat participants. Ann. Am. Thorac. Soc. 15, 200\u2013208 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"24657_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1378\/chest.10-1721","volume":"139","author":"F Garcia-Rio","year":"2011","unstructured":"Garcia-Rio, F. et al. Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life. Chest 139, 1072\u20131080 (2011).","journal-title":"Chest"},{"key":"24657_CR19","doi-asserted-by":"publisher","first-page":"1702681","DOI":"10.1183\/13993003.02681-2017","volume":"51","author":"Y Colak","year":"2018","unstructured":"Colak, Y. et al. Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: A population-based prospective cohort study. Eur. Respir. J. 51, 1702681. https:\/\/doi.org\/10.1183\/13993003.02681-2017 (2018).","journal-title":"Eur. Respir. J."},{"key":"24657_CR20","first-page":"346","volume":"7","author":"M Strand","year":"2020","unstructured":"Strand, M. et al. A risk prediction model for mortality among smokers in the COPDGene(R) study. Chronic Obstr. Pulm. Dis. 7, 346\u2013361 (2020).","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"24657_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1164\/rccm.201804-0663OC","volume":"198","author":"ES Wan","year":"2018","unstructured":"Wan, E. S. et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene Study. Am. J. Respir. Crit. Care Med. 198, 1397\u20131405 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1378\/chest.13-0799","volume":"145","author":"H Petersen","year":"2014","unstructured":"Petersen, H. et al. Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest 145, 695\u2013703 (2014).","journal-title":"Chest"},{"key":"24657_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1164\/ajrccm.163.1.9906089","volume":"163","author":"KA Griffith","year":"2001","unstructured":"Griffith, K. A. et al. Predictors of loss of lung function in the elderly: The Cardiovascular Health Study. Am. J. Respir. Crit. Care Med. 163, 61\u201368 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.resinv.2015.05.005","volume":"53","author":"S Takahashi","year":"2015","unstructured":"Takahashi, S. & Betsuyaku, T. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries. Respir. Investig. 53, 259\u2013270 (2015).","journal-title":"Respir. Investig."},{"key":"24657_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","volume":"203","author":"DMG Alpin","year":"2021","unstructured":"Alpin, D. M. G. et al. Global Initiative for the diagnosis, management, and prevention of chronic obstructive lung disease: The 2020 GOLD science committee report on COVID-19 & COPD. Am. J. Respir. Crit. Care Med. 203, 24\u201336 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR26","first-page":"427","volume":"81","author":"Y Okada","year":"2019","unstructured":"Okada, Y. et al. Renewed Japanese spirometric reference variables and risk stratification for postoperative outcomes in COPD patients with resected lung cancer. Nagoya J. Med. Sci. 81, 427\u2013438 (2019).","journal-title":"Nagoya J. Med. Sci."},{"key":"24657_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.amjmed.2019.06.049","volume":"133","author":"GR Washko","year":"2020","unstructured":"Washko, G. R. et al. Adult life-course trajectories of lung function and the development of emphysema: The CARDIA Lung Study. Am. J. Med. 133, 222-230 e211 (2020).","journal-title":"Am. J. Med."},{"key":"24657_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1411532","volume":"373","author":"P Lange","year":"2015","unstructured":"Lange, P. et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N. Engl. J. Med. 373, 111\u2013122 (2015).","journal-title":"N. Engl. J. Med."},{"key":"24657_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.resinv.2017.11.011","volume":"56","author":"K Sato","year":"2018","unstructured":"Sato, K. et al. Impact of cigarette smoking on decline in forced expiratory volume in 1s relative to severity of airflow obstruction in a Japanese general population: The Yamagata-Takahata study. Respir. Investig. 56, 120\u2013127 (2018).","journal-title":"Respir. Investig."},{"key":"24657_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2466-10-33","volume":"10","author":"L Laviolette","year":"2010","unstructured":"Laviolette, L. et al. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm. Med. 10, 33 (2010).","journal-title":"BMC Pulm. Med."},{"key":"24657_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/15412555.2017.1383978","volume":"14","author":"S Zewari","year":"2017","unstructured":"Zewari, S., Vos, P. V., den Elshout, F., Dekhuijzen, R. & Heijdra, Y. Obesity in COPD: Revealed and unrevealed issues. COPD 14, 663\u2013673 (2017).","journal-title":"COPD"},{"key":"24657_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1164\/rccm.200706-875OC","volume":"178","author":"TG Babb","year":"2008","unstructured":"Babb, T. G., Ranasinghe, K. G., Comeau, L. A., Semon, T. L. & Schwartz, B. Dyspnea on exertion in obese women: Association with an increased oxygen cost of breathing. Am. J. Respir. Crit. Care Med. 178, 116\u2013123 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR33","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1164\/rccm.200904-0530OC","volume":"180","author":"J Ora","year":"2009","unstructured":"Ora, J. et al. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am. J. Respir. Crit. Care Med. 180, 964\u2013971 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1183\/09031936.00195212","volume":"42","author":"A Agusti","year":"2013","unstructured":"Agusti, A. et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur. Respir. J. 42, 636\u2013646 (2013).","journal-title":"Eur. Respir. J."},{"key":"24657_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1164\/rccm.201505-0894OC","volume":"192","author":"RP Young","year":"2015","unstructured":"Young, R. P. et al. Airflow limitation and histology shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am. J. Respir. Crit. Care Med. 192, 1060\u20131067 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24657_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023673","volume":"9","author":"H Ogata","year":"2019","unstructured":"Ogata, H. et al. Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study. BMJ Open 9, e023673. https:\/\/doi.org\/10.1136\/bmjopen-2018-023673 (2019).","journal-title":"BMJ Open"},{"key":"24657_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177032","volume":"12","author":"R Perez-Padilla","year":"2017","unstructured":"Perez-Padilla, R. et al. Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America. PLoS ONE 12, e0177032. https:\/\/doi.org\/10.1371\/journal.pone.0177032 (2017).","journal-title":"PLoS ONE"},{"key":"24657_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.mayocp.2018.05.026","volume":"93","author":"S Mirza","year":"2018","unstructured":"Mirza, S., Clay, R. D., Koslow, M. A. & Scanlon, P. D. COPD Guidelines: A review of the 2018 GOLD report. Mayo Clin. Proc. 93, 1488\u20131502 (2018).","journal-title":"Mayo Clin. Proc."},{"key":"24657_CR39","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3\u201395-year age range: the global lung function 2012 equations. Eur. Respir. J. 40, 1324\u20131343 (2012).","journal-title":"Eur. Respir. J."},{"key":"24657_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4274\/MMJ.galenos.2022.06787","volume":"37","author":"E Ertan Yazar","year":"2022","unstructured":"Ertan Yazar, E. et al. How to utilize CAT and mMRC scores to assess symptom status of patients with COPD in clinical practice?. Medeni Med. J. 37, 173\u2013179 (2022).","journal-title":"Medeni Med. J."},{"key":"24657_CR41","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2147\/COPD.S82408","volume":"10","author":"T Perez","year":"2015","unstructured":"Perez, T. et al. Modified Medical Research Council scale vs. Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 1663\u20131672 (2015).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"24657_CR42","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1183\/09031936.00012408","volume":"32","author":"DM Mannino","year":"2008","unstructured":"Mannino, D. M. et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 32, 962\u2013969 (2008).","journal-title":"Eur. Respir. J."},{"key":"24657_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/15412555.2019.1614550","volume":"16","author":"FJJ Triest","year":"2019","unstructured":"Triest, F. J. J. et al. Airflow obstruction and cardio-metabolic comorbidities. COPD 16, 109\u2013117 (2019).","journal-title":"COPD"},{"key":"24657_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","volume":"52","author":"M Kubota","year":"2014","unstructured":"Kubota, M. et al. Clinical Pulmonary Functions Committee of the Japanese Respiratory S: Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir. Investig. 52, 242\u2013250 (2014).","journal-title":"Respir. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24657-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:19:20Z","timestamp":1669162760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24657-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24657"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24657-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"27 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. K, S. M, H. M, N. N, N. T, T. O, T.K, and T. H have nothing to disclose. S. S reports a grant from Nippon Boehringer Ingelheim Co. and grants from Philips-Respironics, Fukuda Denshi, Fukuda Lifetec Keiji, and ResMed that did not pertain to the submitted work. H. S, and T. N, report grants from Philips-Respironics, Fukuda Denshi, Fukuda Lifetec Keiji, ResMed. K. M reports grants from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Keiji, ResMed and Japan Society for the Promotion of Science, none of which pertained to the submitted work. Y. T reports grants from the Japan Agency for Medical Research and Development (AMED) and The Ministry of Education, Culture, Sports, Science and Technology in Japan during the study period. K. C reports grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology; grants from the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, the Ministry of Health, Labour and Welfare, Japan; grants from the Research Foundation for Healthy Ageing; grants from Health, Labour and Welfare Sciences Research Grants, Research on Region Medical; grants from the Center of Innovation Program and the Global University Project from Japan Science and Technology Agency, Japan Agency for Medical Research and Development during the study period; grants and personal fees from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Tokyo, Fukuda Lifetec Keiji, GlaxoSmithKline and Resmed; grants from KYORIN Pharmaceutical Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd; personal fees from MSD, Astellas Pharma and Eisai Co., Ltd; none of these pertained to the submitted work. F. M reports grants from Kyoto University, the Ministry of Education, Culture, Sports, Science and Technology in Japan, Japan Agency for Medical Research and Development (AMED) and The Takeda Medical Research Foundation during the study period.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20060"}}